Titre : Mortalité périnatale

Mortalité périnatale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Platelet Transfusion
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mortalité périnatale : Questions médicales les plus fréquentes", "headline": "Mortalité périnatale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mortalité périnatale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-02", "dateModified": "2025-03-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mortalité périnatale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mortalité infantile", "url": "https://questionsmedicales.fr/mesh/D007226", "about": { "@type": "MedicalCondition", "name": "Mortalité infantile", "code": { "@type": "MedicalCode", "code": "D007226", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.308.985.550.475" } } }, "about": { "@type": "MedicalCondition", "name": "Mortalité périnatale", "alternateName": "Perinatal Mortality", "code": { "@type": "MedicalCode", "code": "D054238", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Keelin O'Donoghue", "url": "https://questionsmedicales.fr/author/Keelin%20O%27Donoghue", "affiliation": { "@type": "Organization", "name": "Pregnancy Loss Research Group (PLRG), Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland." } }, { "@type": "Person", "name": "Richard Greene", "url": "https://questionsmedicales.fr/author/Richard%20Greene", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynaecology, School of Medicine and Health, University College Cork, Cork, Ireland." } }, { "@type": "Person", "name": "Sara Leitao", "url": "https://questionsmedicales.fr/author/Sara%20Leitao", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynaecology, School of Medicine and Health, University College Cork, Cork, Ireland." } }, { "@type": "Person", "name": "K S Joseph", "url": "https://questionsmedicales.fr/author/K%20S%20Joseph", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynaecology, School of Population and Public Health, University of British Columbia and the Children's and Women's Hospital and Health Centre of British Columbia, Vancouver, British Columbia, Canada." } }, { "@type": "Person", "name": "Alfred Körblein", "url": "https://questionsmedicales.fr/author/Alfred%20K%C3%B6rblein", "affiliation": { "@type": "Organization", "name": "Untere Söldnersgasse 8, D-90403, Nürnberg, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Effect of thrombopoietin receptor agonist on health-related quality of life and platelet transfusion burden for patients with myelodysplastic syndromes: a systematic review and meta-analysis.", "datePublished": "2022-08-17", "url": "https://questionsmedicales.fr/article/35976414", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00277-022-04950-4" } }, { "@type": "ScholarlyArticle", "name": "Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storage.", "datePublished": "2023-02-18", "url": "https://questionsmedicales.fr/article/36802055", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/trf.17285" } }, { "@type": "ScholarlyArticle", "name": "A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates: An experience from a tertiary healthcare center in India.", "datePublished": "2022-06-03", "url": "https://questionsmedicales.fr/article/35667592", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tracli.2022.05.001" } }, { "@type": "ScholarlyArticle", "name": "How do we forecast tomorrow's transfusion? - Next generation transfusion practices to improve recipient safety.", "datePublished": "2022-09-09", "url": "https://questionsmedicales.fr/article/36096445", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tracli.2022.09.005" } }, { "@type": "ScholarlyArticle", "name": "Recommendations for transfusion of blood products in neonatology.", "datePublished": "2022-06-18", "url": "https://questionsmedicales.fr/article/35725819", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.anpede.2022.05.003" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Méthodes épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D004812" }, { "@type": "ListItem", "position": 5, "name": "Collecte de données", "item": "https://questionsmedicales.fr/mesh/D003625" }, { "@type": "ListItem", "position": 6, "name": "Registre civil", "item": "https://questionsmedicales.fr/mesh/D014798" }, { "@type": "ListItem", "position": 7, "name": "Mortalité", "item": "https://questionsmedicales.fr/mesh/D009026" }, { "@type": "ListItem", "position": 8, "name": "Mortalité infantile", "item": "https://questionsmedicales.fr/mesh/D007226" }, { "@type": "ListItem", "position": 9, "name": "Mortalité périnatale", "item": "https://questionsmedicales.fr/mesh/D054238" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mortalité périnatale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mortalité périnatale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mortalité périnatale", "description": "Comment diagnostiquer la mortalité périnatale ?\nQuels examens sont nécessaires pour évaluer la mortalité périnatale ?\nQuels indicateurs sont utilisés pour évaluer la mortalité périnatale ?\nComment les données de mortalité périnatale sont-elles collectées ?\nQuel rôle joue l'autopsie dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=7#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mortalité périnatale", "description": "Quels sont les symptômes associés à la mortalité périnatale ?\nComment reconnaître un décès fœtal in utero ?\nQuels signes peuvent indiquer une complication périnatale ?\nQuels sont les signes cliniques d'un nouveau-né décédé ?\nComment évaluer la santé d'un nouveau-né à risque ?", "url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=7#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mortalité périnatale", "description": "Quelles mesures préventives peuvent réduire la mortalité périnatale ?\nComment l'éducation prénatale aide-t-elle à prévenir la mortalité périnatale ?\nQuel rôle joue le suivi médical dans la prévention ?\nComment la vaccination peut-elle influencer la mortalité périnatale ?\nPourquoi est-il important de gérer les maladies maternelles ?", "url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=7#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mortalité périnatale", "description": "Quels traitements sont disponibles pour prévenir la mortalité périnatale ?\nComment traiter une détresse néonatale ?\nQuels médicaments peuvent réduire les risques périnataux ?\nQuel rôle joue la césarienne dans la mortalité périnatale ?\nComment gérer les grossesses à risque ?", "url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=7#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mortalité périnatale", "description": "Quelles sont les complications courantes liées à la mortalité périnatale ?\nComment les anomalies congénitales affectent-elles la mortalité périnatale ?\nQuel impact a l'hypoxie sur le fœtus ?\nComment les infections maternelles influencent-elles la mortalité périnatale ?\nQuelles sont les conséquences d'une prématurité sur la mortalité périnatale ?", "url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=7#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mortalité périnatale", "description": "Quels sont les principaux facteurs de risque de mortalité périnatale ?\nComment le tabagisme affecte-t-il la mortalité périnatale ?\nQuel rôle joue la nutrition maternelle dans la mortalité périnatale ?\nComment les antécédents médicaux influencent-ils les risques ?\nQuel impact a l'accès aux soins prénatals sur la mortalité périnatale ?", "url": "https://questionsmedicales.fr/mesh/D054238?mesh_terms=Platelet+Transfusion&page=7#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la mortalité périnatale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'analyse des certificats de décès et des dossiers médicaux." } }, { "@type": "Question", "name": "Quels examens sont nécessaires pour évaluer la mortalité périnatale ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des échographies, des analyses sanguines et des examens post-mortem peuvent être requis." } }, { "@type": "Question", "name": "Quels indicateurs sont utilisés pour évaluer la mortalité périnatale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les taux de mortalité, les causes de décès et les facteurs de risque sont des indicateurs clés." } }, { "@type": "Question", "name": "Comment les données de mortalité périnatale sont-elles collectées ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont collectées par les systèmes de santé publique et les registres de décès." } }, { "@type": "Question", "name": "Quel rôle joue l'autopsie dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'autopsie peut aider à déterminer la cause de décès et à identifier des anomalies." } }, { "@type": "Question", "name": "Quels sont les symptômes associés à la mortalité périnatale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent l'absence de battements cardiaques fœtaux et des signes de détresse néonatale." } }, { "@type": "Question", "name": "Comment reconnaître un décès fœtal in utero ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'absence de mouvements fœtaux et l'absence de battements cardiaques à l'échographie sont des signes." } }, { "@type": "Question", "name": "Quels signes peuvent indiquer une complication périnatale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements vaginaux, des douleurs abdominales ou une diminution des mouvements fœtaux peuvent indiquer des complications." } }, { "@type": "Question", "name": "Quels sont les signes cliniques d'un nouveau-né décédé ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent une pâleur, une rigidité cadavérique et l'absence de respiration." } }, { "@type": "Question", "name": "Comment évaluer la santé d'un nouveau-né à risque ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation inclut l'examen physique, la surveillance des signes vitaux et des tests de laboratoire." } }, { "@type": "Question", "name": "Quelles mesures préventives peuvent réduire la mortalité périnatale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des soins prénatals réguliers, une nutrition adéquate et l'évitement de substances nocives sont essentiels." } }, { "@type": "Question", "name": "Comment l'éducation prénatale aide-t-elle à prévenir la mortalité périnatale ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation prénatale informe les parents sur les soins et les signes de complications." } }, { "@type": "Question", "name": "Quel rôle joue le suivi médical dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier permet de détecter et de traiter les problèmes de santé précocement." } }, { "@type": "Question", "name": "Comment la vaccination peut-elle influencer la mortalité périnatale ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination des mères peut protéger les nouveau-nés contre certaines infections." } }, { "@type": "Question", "name": "Pourquoi est-il important de gérer les maladies maternelles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des maladies maternelles réduit les risques de complications pour le fœtus et le nouveau-né." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour prévenir la mortalité périnatale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des soins prénatals appropriés et la gestion des complications." } }, { "@type": "Question", "name": "Comment traiter une détresse néonatale ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure l'assistance respiratoire, la réanimation et des soins intensifs." } }, { "@type": "Question", "name": "Quels médicaments peuvent réduire les risques périnataux ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les corticostéroïdes peuvent aider à maturer les poumons fœtaux." } }, { "@type": "Question", "name": "Quel rôle joue la césarienne dans la mortalité périnatale ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La césarienne peut être nécessaire pour éviter des complications lors de l'accouchement." } }, { "@type": "Question", "name": "Comment gérer les grossesses à risque ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Une surveillance accrue et des interventions médicales précoces sont essentielles pour les grossesses à risque." } }, { "@type": "Question", "name": "Quelles sont les complications courantes liées à la mortalité périnatale ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'hypoxie, les infections et les anomalies congénitales." } }, { "@type": "Question", "name": "Comment les anomalies congénitales affectent-elles la mortalité périnatale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les anomalies congénitales peuvent entraîner des décès fœtaux ou néonatals en raison de malformations graves." } }, { "@type": "Question", "name": "Quel impact a l'hypoxie sur le fœtus ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'hypoxie peut provoquer des lésions cérébrales et augmenter le risque de mortalité périnatale." } }, { "@type": "Question", "name": "Comment les infections maternelles influencent-elles la mortalité périnatale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les infections maternelles peuvent se transmettre au fœtus et entraîner des complications graves." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une prématurité sur la mortalité périnatale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La prématurité augmente le risque de complications et de décès néonatal en raison d'organes immatures." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de mortalité périnatale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge maternel avancé, les maladies chroniques et les grossesses multiples." } }, { "@type": "Question", "name": "Comment le tabagisme affecte-t-il la mortalité périnatale ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme augmente le risque de complications et de décès fœtal en raison de l'hypoxie." } }, { "@type": "Question", "name": "Quel rôle joue la nutrition maternelle dans la mortalité périnatale ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise nutrition peut entraîner des complications comme la prématurité et le faible poids à la naissance." } }, { "@type": "Question", "name": "Comment les antécédents médicaux influencent-ils les risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de complications obstétricales augmentent le risque de mortalité périnatale." } }, { "@type": "Question", "name": "Quel impact a l'accès aux soins prénatals sur la mortalité périnatale ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un accès limité aux soins prénatals augmente le risque de complications et de décès." } } ] } ] }

Sources (7121 au total)

Effect of thrombopoietin receptor agonist on health-related quality of life and platelet transfusion burden for patients with myelodysplastic syndromes: a systematic review and meta-analysis.

Thrombocytopenia is a common and unsolved problem in myelodysplastic syndrome (MDS) patients; we aimed to summarize the evidence of TPO-RA treatment for heath-related quality of life (HRQoL) and plate...

Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storage.

France converted to universal pathogen reduced (PR; amotosalen/UVA) platelets in 2017 and extended platelet component (PC) shelf-life from 5- to 7-days in 2018 and 2019. Annual national hemovigilance ... Data were extracted from published annual HV reports. Apheresis and pooled buffy coat [BC] PC use was compared. Transfusion reactions (TRs) were stratified by type, severity, and causality. Trends wer... PC use increased by 19.1% between 2010 and 2020. Pooled BC PC production increased from 38.8% to 68.2% of total PCs. Annual changes in PCs issued averaged 2.4% per year at baseline, -0.02% (P1) and 2.... Longitudinal HV analysis demonstrated stable PC utilization trends with reduced patient risk during conversion to universal 7-day amotosalen/UVA PCs....

A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates: An experience from a tertiary healthcare center in India.

ABO incompatible single donor platelet concentrates (SDPC) have a concern about unsatisfactory increments as well as possibility of hemolytic transfusion reaction. But from Indian population no study ...

Platelet transfusion.

Platelet transfusions, used as prophylaxis or treatment for bleeding, are potentially life-saving. In many countries, demand for platelet transfusion is rising. Platelets are a limited and costly reso... Recent randomized clinical trials demonstrate the efficacy of platelet transfusions in some contexts but potential detrimental effects in others. Platelet transfusions also carry risk of transfusion r... Although platelet transfusions are beneficial in many patients, there remain many settings in which the optimal use of platelet transfusions is unclear, and some situations in which they may have detr...

Efficacy and safety of platelet additive solution-E stored platelet concentrates.

In 2018, platelet (PLT) additive solution-E (PAS-E) was introduced. The implementation of PAS-E was expected to diminish the number of allergic reactions in recipients following a PLT transfusion. Her... After implementation of PAS-E, data were collected from 2 cohorts of patients with hematological disorders as well as oncology patients, receiving PLTs in PAS-E. A similar patient group in a recent RC... In cohort 1, the mean 1-h CCI was 14.3 ± 6.9, and the 24-h CCI was 8.7 ± 5.6. In cohort 2, the 1-h CCI was 11.6 ± 7.8 and the 24-h CCI was 7.0 ± 6.1. In the control group, the 1-h CCI was 15.4 ± 5.5 a... The CCIs of PLTs in PAS-E were decreased compared to plasma PCs, but clinically acceptable. Allergic transfusion reactions were decreased in PAS-E PCs compared to plasma PCs....

Contamination of platelet concentrates with Staphylococcus aureus induces significant modulations in platelet functionality.

Platelet concentrates (PCs) contaminated with Staphylococcus aureus can escape detection during PC screening, causing septic transfusion reactions. This study aimed to determine the impact of S. aureu... Targeted metabolomics (N = 3) was performed on non-spiked PCs and PCs inoculated with 10-20 colony-forming units (CFU)/bag of S. aureus. Metabolites were quantified at 0, 48 and 144 h using high-perfo... Eight metabolites had significantly different levels in spiked PCs (log2 fold-change ≤ or ≥±1) versus non-spiked units at 48 and 144 h. Xanthine, uridine, serine, glutamine and threonine were increase... Contamination with S. aureus exacerbates platelet storage lesions in contaminated PCs but only when the bacterium has reached clinically significant levels....

Survey of transfusion practices in preterm infants in Europe.

Preterm infants commonly receive red blood cell (RBC), platelet and fresh frozen plasma (FFP) transfusions. The aim of this Neonatal Transfusion Network survey was to describe current transfusion prac... From October to December 2020, we performed an online survey among 597 neonatal intensive care units (NICUs) caring for infants with a gestational age (GA) of <32 weeks in 18 European countries.... Responses from 343 NICUs (response rate: 57%) are presented and showed substantial variation in clinical practice. For RBC transfusions, 70% of NICUs transfused at thresholds above the restrictive thr... Transfusion thresholds and aspects of administration vary widely across European NICUs. In general, transfusion thresholds used tend to be more liberal compared with data from recent trials supporting...

Two novel platelet biotinylation methods and their impact on stored platelet concentrates in a blood bank environment.

Storage of platelet concentrates (PCs) has an impact on platelet quality and possibly affects their functions after transfusion. The influence of processing and storage conditions of PCs on their in v... Two methods of biotinylation were compared to a control (standard PC). The "Bio-Wash" process used washing steps to label all platelets within the PC; for the other method, "Bio-Direct," one fifth of ... Both methods achieved a stable labeling through the storage, with similar platelet counts and metabolism in comparison to control PCs. Bio-Wash showed higher activation phenotype and lower aggregation... We set up two methods of biotinylation that can be easily implemented in a blood bank environment. The Bio-Direct process was preferred to the Bio-Wash because of its similarity, from a functional and...